Shortage of dextroamphetamine tablets

The American Society of Health-System Pharmacists reports a shortage of dextroamphetamine tablets. Teva is the sole supplier approved by the FDA, and gave no reason for the shortage. It seem likely, however, that this shortage is a continuing effect of the ongoing shortages of amphetamine mixed salts and methylphenidate. All of these are used to treat attention-deficit hyperactivity disorder.